This study aims to identify the mechanism of temozolomide (TMZ) resistance in GBM.<h4>Methods</h4>Bioinformatics and antibody-based protein detection were used to examine the expression of E2F7 in gliomas and its correlation with prognosis. Here, E2F7 is linked to glioblastoma.